Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Investigational drug for ED discovered by Fujisawa now licensed to TAP

Nov. 10, 2000

Phase II trial results for Alprox-TD in ED announced by NexMed

Nov. 8, 2000

Actinomycin D presented in Singapore as potential stroke-related incontinence therapy

Nov. 7, 2000

Botox provides sustained improvement to patients with drug-resistant detrusor hyperreflexia

Nov. 6, 2000

Relaxant effects of KRP-197 on human urinary bladder discussed at SIU congress

Nov. 6, 2000

Effects of Ono-8711, a selective EP1 receptor antagonist, on rat urinary bladder

Nov. 6, 2000

New treatments for sexual dysfunction and cardiovascular disorders disclosed by BMS

Nov. 3, 2000

EMD-221829, a new PDE5 inhibitor: correlation of pharmacokinetics and pharmacodynamics

Nov. 2, 2000

Nastech's intranasal apomorphine enters phase II for MED

Oct. 31, 2000

Antifibrotic agents patented by Sumitomo

Oct. 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...